Regenerative biotechnology
Gencell® CTM Inmunoboost
Immunomodulatory cellular combination with MSCs and memory Natural Killer cells.
Injectable solution that combines mesenchymal stem cells pretreated with melatonin and allogeneic memory Natural Killer cells for immune reinforcement and controlled tissue repair.
Composition
CTM pretreated with melatonin and allogeneic NK cells.
Pharmaceutical form
Injectable solution.
Presentation
Monovette with 4 ml.
Therapeutic Properties
Immunomodulatory and regenerative action through the synergy of CTM and memory NK cells, reducing inflammation, promoting tissue repair, improving endothelial function, and eliminating infected or neoplastic cells without exacerbating the inflammatory response.
- Strengthening of the immune response.
- Reduction of systemic inflammation.
- Elimination of infected cells.
- Support in severe viral infections.
- Support in severe bacterial infections.
- Repair of damaged tissues.
- Regulation of immunosuppression states.
- Improvement of intercellular communication.
Mechanism of action & Clinical data
MSCs migrate and modulate inflammation and tissue regeneration, while memory NK cells induce apoptosis of infected cells through perforins, granzymes, and cytokine release.
Indications
Adjuvant in immunosuppression, severe viral and bacterial infections, chronic infections, sepsis, and autoimmune diseases.
Administration
Intravenous route, slow infusion diluted in 0.9% saline solution, using a Y-connector, not as a bolus.
Contraindications
Sensitivity or allergy to formula components. Diagnosis of neoplasia.
Storage
Store refrigerated between 2 and 8 °C, protected from direct sunlight. Avoid freezing and shaking.
